Sekine Kazuma, Miyao Naoki, Harada Naoko, Akao Masaki, Nakamura Naoya, Kizaki Masahiro, Suzuki Osamu
Department of Internal, Nihonkoukan Hospital.
Nihon Kokyuki Gakkai Zasshi. 2011 Jul;49(7):543-7.
A 62-year-old woman with Sjogren syndrome was admitted for computed tomographic (CT) evaluation of a thickened trachea and parotid tumor. She had been given a diagnosis of mucosa-associated lymphoid tissue (MALT) lymphoma 6 years previously, and had undergone surgical resection of the parotid tumor. Endoscopic examination revealed an annular tumor that had formed a stricture in the mid-trachea. Pathologic specimens were obtained by surgical resection of the parotid tumor and bronchoscopic biopsy of the tracheal tumor. Both histological examinations revealed MALT-type marginal zone B-cell lymphoma. Because CD20 immunostaining was positive, the patient received 6 cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) without any signs of major toxicity. All lesions disappeared after treatment, and this patient remained disease-free for 40 months.
一名62岁的干燥综合征女性因气管增厚和腮腺肿瘤接受计算机断层扫描(CT)评估而入院。她6年前被诊断为黏膜相关淋巴组织(MALT)淋巴瘤,并接受了腮腺肿瘤手术切除。内镜检查发现气管中部有一个形成狭窄的环形肿瘤。通过腮腺肿瘤手术切除和气管肿瘤支气管镜活检获取病理标本。两次组织学检查均显示为MALT型边缘区B细胞淋巴瘤。由于CD20免疫染色呈阳性,该患者接受了6个周期的利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松龙(CHOP)治疗,未出现任何严重毒性迹象。治疗后所有病变均消失,该患者无病生存40个月。